Telesis Bio News

TBIODelisted Stock  USD 2.98  0.02  0.67%   
About 55% of Telesis Bio's investors are presently thinking to get in. The analysis of overall sentiment of trading Telesis Bio pink sheet suggests that some investors are interested at this time. Telesis Bio's investing sentiment overview a quick insight into current market opportunities from investing in Telesis Bio. Many technical investors use Telesis Bio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over a year ago at globenewswire.com         
Telesis Bio Reports Third Quarter 2023 Financial Results
Macroaxis News: globenewswire.com
over a year ago at globenewswire.com         
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
Macroaxis News: globenewswire.com
over a year ago at finance.yahoo.com         
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfecti...
Yahoo News
over a year ago at www.macroaxis.com         
Acquisition by Herrema Gregory J of 153191 shares of Telesis Bio subject to Rule 16b-3
Macroaxis News
over a year ago at benzinga.com         
Telesis Bio Announces Commercial Release of BioXp NGS Library Prep Kit for WGS
benzinga news
over a year ago at news.google.com         
Insider Buyers Lose Additional US54k As Telesis Bio Dips To US34m - Simply Wall St
Google News at Macroaxis
over a year ago at simplywall.st         
Insider Buyers Lose Additional US54k As Telesis Bio Dips To US34m
Simply Wall St News at Macroaxis
over a year ago at finance.yahoo.com         
This Telesis Bio Insider Increased Their Holding In The Last Year
Yahoo News
over a year ago at news.google.com         
Telesis Bio Appoints William Kullback CFO - Nasdaq
Google News at Macroaxis
over a year ago at seekingalpha.com         
Telesis Bio appoints William Kullback as CFO
seekingalpha News
over a year ago at marketwatch.com         
Telesis Bio Names William Kullback Finance Chief
marketwatch News
over a year ago at finance.yahoo.com         
Telesis Bio Appoints William J. Kullback Chief Financial Officer
Yahoo News
over a year ago at insidermonkey.com         
Telesis Bio, Inc. Q2 2023 Earnings Call Transcript
insidermonkey News
over a year ago at benzinga.com         
Pfizer Collaboration Offers Potential Milestone Windfalls For TBIO, Despite Financial Hurdles Analys...
benzinga news
over a year ago at seekingalpha.com         
BofA lowers rating on Telesis Bio to sector weight from overweight
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Telesis Bio that are available to investors today. That information is available publicly through Telesis media outlets and privately through word of mouth or via Telesis internal channels. However, regardless of the origin, that massive amount of Telesis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Telesis Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Telesis Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Telesis Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Telesis Bio alpha.

Telesis Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Telesis Pink Sheet

If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins